Seasoned, Systematic, Successful
Deals / Tombstones: Corporate Finance / Milkhaus Laboratories
Deals

This announcement appears as a matter of record only


Milkhaus Laboratories

Received $5,000,000 for Phase 2 clinical trials from

Current Shareholders

FOCUS Regional Managing Partner William S. Lear assisted in the negotiations as the representative of Milkhaus Laboratories.

 
Complimentary,
middle market monthly email newsletter. Relevant insights, trends, and news. Substance, not fluff.
more information....

Read more about FOCUS Enterprises' various business sector experience... Read More


The FOCUS Capabilities Brochure ...Download


Securities transactions are conducted through Wm. H. Murphy & Co., Inc. a registered broker-dealer member FINRA/SIPC that is not affiliated with FOCUS.

Home | About Us | Services | Sectors | Deals | FOCUS Funds
Publications | News | Privacy Policy | Site Map | Contact Us